Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v3-EN Version v3-EN
Language English English
Date Updated 2019-09-11 2019-09-11
Drug Identification Number 02369362 02369362
Brand name ACUVAIL ACUVAIL
Common or Proper name Ketorolac Ketorolac
Company Name ABBVIE CORPORATION ABBVIE CORPORATION
Ingredients KETOROLAC TROMETHAMINE KETOROLAC TROMETHAMINE
Strength(s) 0.45% 0.45%
Dosage form(s) SOLUTION SOLUTION
Route of administration OPHTHALMIC OPHTHALMIC
Packaging size 60 x 0.4 mL 60 x 0.4 mL
ATC code S01BC S01BC
ATC description ANTIINFLAMMATORY AGENTS ANTIINFLAMMATORY AGENTS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2019-09-10 2019-09-10
Actual start date 2019-09-10 2019-09-10
Estimated end date 2019-10-11 2019-10-11
Actual end date
Shortage status Actual shortage Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments